CSF1R and neoplasm: To examine the impact of CSF-1R inhibition on the tumor microenvironment and to relate these to changes in M-MDSCs in blood, mice were sacrificed at day 28, and the immune components within the tumor microenvironment were analyzed by immunohistochemical (IHC) staining.